Sm. Mariani et al., INTERLEUKIN 1-BETA-CONVERTING ENZYME RELATED PROTEASES CASPASES ARE INVOLVED IN TRAIL-INDUCED APOPTOSIS OF MYELOMA AND LEUKEMIA-CELLS/, The Journal of cell biology, 137(1), 1997, pp. 221-229
The Fas/APO-1/CD95 ligand (CD95L) and the recently cloned TRAIL ligand
belong to the TNF-family and share the ability to induce apoptosis in
sensitive target cells, Little information is available on the degree
of functional redundancy between these two ligands in terms of target
selectivity and intracellular signalling pathway(s). To address these
issues, we have expressed and characterized recombinant mouse TRAIL.
Specific detection with newly developed rabbit anti-TRAIL antibodies s
howed that the functional TRAIL molecule released into the supernatant
of recombinant baculovirus-infected Sf9 cells is very similar to that
associated with the membrane fraction of Sf9 cells. CD95L resistant m
yeloma cells were found to be sensitive to TRAIL, displaying apoptotic
features similar to those of the CD95L- and TRAIL-sensitive T leukemi
a cells Jurkat. To assess if IL-1 beta-converting enzyme (ICE) and/or
ICE-related proteases (IRPs) (caspases) are involved in TRAIL-induced
apoptosis of both cell types, peptide inhibition experiments were perf
ormed. The irreversible IRP/caspase-inhibitor Ac-YVAD-cmk and the reve
rsible IRP/caspase-inhibitor Ac-DEVD-CHO blocked the morphological cha
nges, disorganization of plasma membrane phospholipids, DNA fragmentat
ion, and loss of cell viability associated with TRAIL-induced apoptosi
s. In addition, cells undergoing TRAIL-mediated apoptosis displayed cl
eavage of poly(ADP)-ribose polymerase (PARP) that was completely block
ed by Ac-DEVD-CHO. These results indicate that TRAIL seems to compleme
nt the activity of the CD95 system as it allows cells, otherwise resis
tant, to undergo apoptosis triggered by specific extracellular ligands
. Conversely, however, induction of apoptosis in sensitive cells by TR
AIL involves IRPs/caspases in a fashion similar to CD95L. Thus, differ
ential sensitivity to CD95L and TRAIL seems to map to the proximal sig
naling events associated with receptor triggering.